United States · FDA National Drug Code directory
Potassium Phosphates
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-077_2f2fccc5-9cbf-27d6-e063-6294a90a55f9
- Product NDC
- 69097-077
- Form
- INJECTION
- Composition / generic term
- Potassium Phosphates
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250206
- Source listing expiry
- 20261231
Source-listed ingredients
- MONOBASIC POTASSIUM PHOSPHATE — 224 mg/mL
- DIBASIC POTASSIUM PHOSPHATE — 236 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (69097-077-97) / 15 mL in 1 VIAL (69097-077-67) · 69097-077-97
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →